Real World Data for Competitive Advantage

2016 Speaking Faculty

Nate Crisel
Head of Real World Informatics and Analytics
Astellas Pharma, Inc.

Omar Dabbous
Head, Health Economics and Outcomes Research
Halozyme Therapeutics

Jennifer Dunphy, MBA, MPH
Director, Population Health
Regal Medical Group

Jesse Fishman
Scientific and Real World Data Alliances Lead
UCB

Andres Gomez, PhD, MPH
Head of Epidemiology, Safety Science and Analytics, Global Pharmacovigilance and Epidemiology
Bristol Myers Squibb

James Harnett, PharmD, MS
Sr. Director, Analytical Sciences Lead, Real World Data and Analytics, Global Health and Value
Pfizer

Usman Iqbal, MD, MPH, MBA
Senior Medical Affairs Leader
AstraZeneca

Kristijan Kahler, RPh, PhD
CoE for Real World Evidence, Head, Outcomes Evidence & Analytics
Novartis

Rama Kondru, Ph.D
Global Head, Data Sciences and Advanced Analytics, Pharma IT
Johnson and Johnson

Steven Labkoff, MD, FACP, FACMI
Executive Director, Medical Strategy
Purdue Pharma

Julie C. Locklear, PharmD, MBA
Vice President & Head, Health Economics & Outcomes Research
EMD Serono

Kerry McDermott, MPH
Vice President, Public Policy & Communications
Center for Medical Interoperability

Kathleen McGroddy Goetz, Ph.D.
Vice President, Partnerships & Solutions
IBM Watson Health

Joseph Menzin, PhD
President
Boston Health Economics, Inc.

Kate Mulroney
Senior Director & Global Lead, Big Data Analytics Center of Excellence
Novo Nordisk

Amy Phillips, PharmD
Director, Health Economics and Outcomes Research
EMD Serono

Igor Rudychev
Director, Commercial Analytics, Resource Allocation Team Leader
Pfizer Pharmaceuticals

Judy Sewards
Vice President, Digital Strategy & Data Innovation
Pfizer

Avani Shah, MPH
Data Strategy and Acquisition Manager
Genentech

Todd A. Townsend, Ph.D.
Commissioner’s Fellow
United States Food & Drug Administration

Xiaoying Wu, M.D. M.S
Director, RWE and IT COE
Johnson and Johnson